Verified peer comparison
Glaukos vs ADMA Biologics Financial Comparison
Direct answer
Glaukos and ADMA Biologics are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Glaukos email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Glaukos Revenue
- 507,442,000 USD
- ADMA Biologics Revenue
- 510,173,000 USD
- Glaukos Operating income
- -86,733,000 USD
- ADMA Biologics Operating income
- 191,443,000 USD